A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single-center analysis.

Amelework WodajoRavi SarodeShiney ValiyaparambilChristopher WebbNicole De SimoneDill RebeccaAmena Usmani

Published in: Transfusion (2024)

Our findings suggest that a pre-procedure fibrinogen threshold of 80-100 mg/dL without plasma supplementation does not increase bleeding risk unless patients were on anticoagulation.

Keyphrases

atrial fibrillation
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
minimally invasive
venous thromboembolism
breast cancer risk